Business Context and Reporting Period
Company: iSpecimen Inc. (ISPC)
Filing Type: Form 8-K (Current Report)
Date of Report: November 28, 2025
Reporting Period: Event date November 28, 2025; Financial data referenced from the period ended September 30, 2025.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or debt metrics directly. It references the following financial figure from the Company's Form 10-Q for the period ended September 30, 2025:
- Stockholders' Equity: $3,072,711
The filing does not provide clear values for liquidity, margins, or debt levels.
Material Changes
The primary material change is the resolution of a listing deficiency:
- Previous Status: On June 4, 2025, the Nasdaq Listing Qualifications Staff notified the Company of non-compliance with minimum stockholders' equity, market value of listed securities, or net income requirements (Nasdaq Listing Rules 5550(b)(1), 5550(b)(2), and 5550(b)(3)).
- Current Status: On November 28, 2025, the Staff determined the Company has regained compliance based on the September 30, 2025, stockholders' equity figure. The matter is now closed.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the Company has met the criteria to remain listed on the Nasdaq Capital Market.
Risks and Contingencies: The immediate risk of delisting due to the previously cited equity and market value deficiencies has been resolved as of the report date. No new risks or unusual items are disclosed in this specific filing.
Investor Verification Checklist
- Verify the Company's current stock price and market capitalization to ensure continued compliance with Nasdaq market value rules.
- Review the Form 10-Q for the period ended September 30, 2025, to confirm the $3,072,711 stockholders' equity figure and assess overall financial health.
- Monitor future filings for any recurrence of non-compliance notices regarding stockholders' equity or net income.